期刊文献+

2012年版《WHO乳腺肿瘤分类》新变化与临床治疗的关系 被引量:8

原文传递
导出
摘要 近年来,乳腺肿瘤临床治疗模式和理念有着新的转变,治疗技术和方法得到了快速的发展,形成更加规范化并且更加注重个体化的趋势.与此同时,分子病理学研究的新成果新发现使人类对疾病的理解更深入,为治疗手段的改进提供了有力证据和开辟了新的途径.乳腺病理学分类也在随之不断地更新和增加内容,朝着更加适合临床治疗需求、体现同病异治、异病同治新理念的方向发展和完善.2012年新版《WHO乳腺肿瘤分类》(以下简称2012新版分类)与2003年版比较,有了许多新变化,本文就这些新变化与临床治疗的关系与临床及病理的同道们一起探讨.
作者 牛昀
出处 《中华乳腺病杂志(电子版)》 CAS 2014年第3期1-5,共5页 Chinese Journal of Breast Disease(Electronic Edition)
  • 相关文献

参考文献24

  • 1Lakhani SR,Ellis IO,Schnitt SJ,et al.WHO classification of tumors of the breast[M].Lyon:IARC Press,2012:6.
  • 2Tavassoli FA,Devilee P.World Health Organization classification of tumours.Pathology & genetics of tumors of the breast and female genital organs[M].Lyon:IARC Press,2003:10-112.
  • 3Rakha EA,Reis-Filho JS,Baehner F,et al.Breast cancer prognostic classification in the molecular era:the role of histological grade[J].Breast Cancer Res,2010,12 (4):207.
  • 4Goldhirsch A,Winer EP,Coates AS,et al.Personalizing the treatment of women with early breast cancer:highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013[J].Ann Oncol,2013,24(9):2206-2223.
  • 5Aleskandarany MA,Rakha EA,Macmillan RD,et al.MIB1/ Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups[J].Breast Cancer Res Treat,2011,127(3):591-599.
  • 6Abdel-Fatah TM,Powe DG,Ball G,et al.Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer[J].J Pathol,2010,222(4):388-399.
  • 7Mackay A,Weigelt B,Grigoriadis A,et al.Microarray-based class discovery for molecular classification of breast cancer:analysis of interobserver agreement[J].J Natl Cancer Inst,2011,103(8):662-673.
  • 8Parker JS,Mullins M,Cheang MC,et al.Supervised risk predictor of breast cancer based on intrinsic subtypes[J].J Clin Oncol,2009,27(8):1160-1167.
  • 9Choi J,Jung WH,Koo JS.Clinicopathologic features of molecular subtypes of triple negative breast cancer based on immunohistochemical markers[J].Histol Histopathol,2012,27(11):1481-1493.
  • 10Ellis IO.Intraductal proliferative lesions of the breast:morphology,associated risk and molecular biology[J].Mod Pathol,2010,23 Suppl 2:S1-7.

同被引文献71

引证文献8

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部